You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2025

Bulk Pharmaceutical API Sources for PEPCID RPD


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PEPCID RPD

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free F6889_SIGMA ⤷  Get Started Free
NIH Clinical Collection ⤷  Get Started Free SAM001247033 ⤷  Get Started Free
Hangzhou Trylead Chemical Technology ⤷  Get Started Free TL8005267 ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 5702160 ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free F0530 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: PEPCID RPD

Last updated: July 29, 2025

Introduction

The demand for effective gastrointestinal treatments has driven the pharmaceutical industry to develop reliable sources of Active Pharmaceutical Ingredients (APIs). PEPCID RPD, known generically as famotidine, is a widely used H2 receptor antagonist indicated for the treatment of gastric ulcers, GERD, and Zollinger-Ellison syndrome. Ensuring the supply chain of high-quality famotidine API is critical for pharmaceutical manufacturers and healthcare providers. This article explores the current bulk API sources for PEPCID RPD (famotidine), analyzing key manufacturers, geographic considerations, quality standards, and procurement strategies vital for stakeholders aiming to optimize their supply chains.

Overview of Famotidine (PEPCID RPD) API

Famotidine is a potent H2 receptor blocker that inhibits gastric acid secretion. The API is synthesized through multi-step chemical processes involving key intermediates derived from precursor compounds. The efficacy and safety of PEPCID RPD depend heavily on the purity, stability, and consistency of the famotidine API supplied by bulk manufacturers.

In the context of pharmaceuticals, API sourcing encompasses regimens that meet stringent regulatory standards, including United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other relevant quality certifications. The API's quality impacts formulation efficacy, regulatory approval, and market acceptance.

Major API Suppliers for Famotidine (PEPCID RPD)

1. Domestic North American Manufacturers

North American pharmaceutical companies have developed robust manufacturing capabilities for famotidine API, often adhering to rigorous cGMP standards to meet FDA and Health Canada regulations.

  • Unichem Laboratories Ltd. (India-based with North American distribution): Known for producing high-quality famotidine APIs with USDMF (Drug Master File) registration. Their API complies with USP and EP standards, making them a preferred choice for North American and European markets.

  • Novartis (Switzerland): Historically involved in API manufacturing, although Novartis has divested some operations, its infrastructure for producing high-quality APIs, including famotidine, remains significant in the industry. These legacy sources often serve as benchmarks for quality compliance.

2. Asian and Indian Manufacturers

India and China dominate the global API production landscape, including famotidine, due to cost advantages and scalable manufacturing bases.

  • Jubilant Life Sciences (India): A leading API supplier with USDMF and DMF (Drug Master File) registrations, Jubilant offers famotidine API compliant with international standards. Their vertical integration ensures quality control across the manufacturing process.

  • Hunan JMT Pharmaceutical Co., Ltd. (China): Offers bulk famotidine API with GMP certification, serving both domestic and export markets. Their focus on quality and cost competitiveness makes them a frequent choice for API procurement.

  • Shanghai Hengrui Pharmaceutical Co., Ltd. (China): Engaged in large-scale API production, Hengrui supplies famotidine API with a focus on meeting international quality standards, including stability and purity requirements.

3. European API Manufacturers

European companies emphasize strict regulatory compliance and high purity standards, often aligning with the EU Pharmacopoeia.

  • Sigma-Aldrich (Merck): Offers famotidine API with rigorous quality documentation, supplied to research and manufacturing sectors worldwide. Their APIs meet USP, EP, and JP standards, providing confidence in quality.

  • Siegfried AG: A Swiss-based producer of pharmaceutical APIs, including famotidine, with GMP-certified facilities and a strong regulatory track record. Siegfried caters primarily to the European and North American markets.

4. Contract Manufacturing Organizations (CMOs)

Many pharmaceutical companies leverage CMOs for API synthesis to gain cost efficiencies and access to specialized expertise.

  • Boehringer Ingelheim: Offers contract manufacturing for APIs, including famotidine, with advanced production facilities capable of meeting global regulatory standards.

  • Recipharm: Provides API manufacturing services, including famotidine with a focus on maintaining high quality and regulatory compliance.

Regional Considerations and Supply Chain Risks

  • Regulatory Environment: Suppliers adhering to cGMP guidelines via USDMF and European Equivalence ensure regulatory acceptance. It’s vital to vet suppliers' compliance documentation during sourcing.

  • Geopolitical Risks: China and India are dominant API suppliers but face geopolitical uncertainties, trade restrictions, and regulatory crackdowns, potentially disrupting supply chains.

  • Quality Control: Ensuring supplier validation through audits, quality certifications, and stability data minimizes risks of substandard APIs entering the supply chain.

  • Supply Security: Diversification across regions and multiple suppliers mitigates risks associated with dependency on a single source, particularly critical during pandemic-related disruptions.

Quality Standards and Certifications for API

  • USDMF and CoA (Certificate of Analysis): Essential documents certifying API compliance with pharmacopeial standards.

  • GMP Certification: Confirms manufacturing processes adhere to Good Manufacturing Practices, ensuring quality and consistency.

  • ISO Certifications: ISO 9001 and ISO 13485 further demonstrate quality management system adherence.

  • Stability and Purity Testing: API manufacturers must provide stability data and purity profiles confirming the API's efficacy over its shelf life.

Procurement Strategies for API Sourcing

  • Supplier Qualification and Audits: Conduct thorough due diligence, including on-site audits and review of quality systems.

  • Long-term Contracts vs. Spot Purchasing: Secure long-term agreements with trusted suppliers to stabilize pricing and availability.

  • Supply Chain Visibility: Establish real-time monitoring of supplier production status, logistics, and regulatory compliance.

  • Regulatory Alignment: Prioritize suppliers with relevant registrations and filings to facilitate faster approval processes during product development or market expansion.

Conclusion

Sourcing high-quality PEPCID RPD (famotidine) API necessitates a comprehensive understanding of global manufacturers, regulatory standards, and supply chain dynamics. Leading suppliers are located predominantly in India, China, Europe, and North America, each offering benefits aligned with cost, quality, and reliability considerations. Strategic diversification, rigorous validation, and close regulatory alignment are vital to mitigate risks and ensure uninterrupted access to high-purity famotidine API.

Key Takeaways

  • Major API suppliers for famotidine include firms in India (Jubilant), China (Hunan JMT, Hengrui), Europe (Siegfried, Sigma-Aldrich), and North America.
  • Ensuring supplier compliance with GMP, USDMF, and EP standards is critical for product quality and regulatory approval.
  • Diversification of sources reduces supply chain risks given geopolitical and manufacturing disruptions.
  • Robust qualification processes, including audits and document review, are essential for reliable sourcing.
  • Continuous monitoring of supply chain performance and regulatory changes enhances procurement resilience.

FAQs

1. What factors should I consider when selecting a famotidine API supplier?
Prioritize suppliers with established cGMP compliance, valid regulatory filings (USDMF/DMF), positive past audit results, and proven stability and purity data for their APIs. Consider geographical diversification to mitigate regional supply risks.

2. How does regional regulation impact API sourcing?
Suppliers must comply with local and international standards (e.g., USP, EP, GMP) to facilitate market approval. Regulatory equivalence and the supplier’s adherence to quality standards streamline approval processes globally.

3. Are Chinese API manufacturers reliable for PEPCID RPD?
Yes, many Chinese manufacturers like Hunan JMT and Hengrui have attained GMP certification and maintain high-quality standards. However, thorough qualification and audits are recommended before procurement.

4. What are the main risks associated with API procurement?
Risks include supply disruptions due to geopolitical issues, quality deviations, non-compliance with regulatory standards, and logistical delays. Diversification, validation, and supplier audits mitigate these risks.

5. How can I ensure API quality during procurement?
Require comprehensive Certificates of Analysis, Certificates of Compliance, stability data, and perform on-site audits if feasible. Maintain stringent quality assurance processes and conduct routine testing of incoming APIs.

References

[1] U.S. Food and Drug Administration. (2022). USDMF Directory.
[2] European Directorate for the Quality of Medicines & HealthCare (EDQM). EP Documentation.
[3] Jubilant Life Sciences. (2023). API Product Portfolio.
[4] Shanghai Hengrui Pharmaceutical. (2023). API Manufacturing Capabilities.
[5] Sigma-Aldrich. (2023). API Product Data Sheets.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.